# Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis

> **NCT03961516** · — · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 34 (actual)

## Conditions studied

- Cystic Fibrosis
- Cystic Fibrosis-related Diabetes
- Cystic Fibrosis Liver Disease
- Pancreatic Steatosis
- Hepatic Steatosis

## Interventions

- **DEVICE:** Frequently Sampled Oral Glucose Tolerance Test and CGM
- **RADIATION:** MRI Pancreas and Liver

## Key facts

- **NCT ID:** NCT03961516
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2022-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03961516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03961516, "Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03961516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*